Athenex, Inc.

Ownership Transactions Reported by 19 Insiders

Industry
Pharmaceutical Preparations
Location
1001 Main Street, Suite 600, Buffalo, NY

There are no Buy or Sell transactions made by insiders since 11/5/2023

Athenex, Inc. executives and other stock owners filed with the SEC include:

Name Relationship Holdings Value Past Year Net Change Change % Report Date
Johnson Yiu Nam Lau CEO and Chairman of the Board, Director $405K May 5, 2023
Jeffrey Yordon COO, and President, Athenex Pharmaceutical Division. $334K Aug 3, 2022
Manson Fok Director $204K Apr 21, 2023
William Wei Zuo President, China Division $194K Aug 3, 2021
Daniel Lang Pres Cell Therapy, VP Corp Dev $111K Sep 16, 2022
Rudolf Kwan EVP, Chief Medical Officer $67.8K May 5, 2023
Jinn Wu Director $47.3K Apr 21, 2023
Jordan Kanfer Director $23.2K Aug 3, 2022
Benson Kwan Hung TSANG Director $23K Apr 21, 2023
John Vierling Director $16.8K Apr 21, 2023
Kim Campbell Director $13.6K Aug 3, 2021
Stephanie A. Davis Director $10.9K Apr 21, 2023
Simon Pedder Officer $7.22K Aug 3, 2021
Michael Smolinski Chief Scientific Officer $7.04K Nov 16, 2021
Robert J. Spiegel Director $6.25K Apr 21, 2023
Timothy DeVere Cook Chief Business and Commercial Officer, Proprietary Drugs $5.63K May 5, 2023
Joe Annoni Chief Financial Officer $510 Feb 22, 2023
Teresa Bair General Counsel, SVP Admin. Aug 3, 2021
Steven J. Adams Interim Chief Acct Officer Aug 3, 2021

Recent Insider Transactions by Companies or Individuals for Athenex, Inc.

Insider Symbol Class Transaction % Value $ * Price $ Shares Shares Owned Date Ownership
* An asterisk sign (*) next to the price indicates that the price is likely invalid.